Pediatrics Vaccines Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Pediatrics Vaccines Market

1.1. Definition and Scope

1.1.1. Definition of Pediatrics Vaccines

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Pediatrics Vaccines Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Pediatrics Vaccines Market By Vaccine Type

1.2.3. Pediatrics Vaccines Market By Technology

1.2.4. Pediatrics Vaccines Market By Indication

1.2.5. Pediatrics Vaccines Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Pediatrics Vaccines Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Pediatrics Vaccines Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Pediatrics Vaccines Market By Vaccine Type

5.1. Introduction

5.2. Pediatrics Vaccines Revenue By Vaccine Type

5.2.1. Pediatrics Vaccines Revenue (USD Billion) and Forecast, By Vaccine Type, 2020-2032

5.2.2. Monovalent

5.2.2.1. Monovalent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Multivalent

5.2.3.1. Multivalent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Pediatrics Vaccines Market By Technology

6.1. Introduction

6.2. Pediatrics Vaccines Revenue By Technology

6.2.1. Pediatrics Vaccines Revenue (USD Billion) and Forecast, By Technology, 2020-2032

6.2.2. Live Attenuated

6.2.2.1. Live Attenuated Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Conjugate

6.2.3.1. Conjugate Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Toxoid

6.2.4.1. Toxoid Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Inactivated

6.2.5.1. Inactivated Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Others

6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Pediatrics Vaccines Market By Indication

7.1. Introduction

7.2. Pediatrics Vaccines Revenue By Indication

7.2.1. Pediatrics Vaccines Revenue (USD Billion) and Forecast, By Indication, 2020-2032

7.2.2. Influenza

7.2.2.1. Influenza Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Varicella

7.2.3.1. Varicella Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Pneumococcal Disease

7.2.4.1. Pneumococcal Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Measles, Mumps and Rubella

7.2.5.1. Measles, Mumps and Rubella Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.6. Rotavirus

7.2.6.1. Rotavirus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.7. Meningococcal Disease

7.2.7.1. Meningococcal Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.8. Human Papilloma Virus

7.2.8.1. Human Papilloma Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.9. Polio

7.2.9.1. Polio Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.10. Diphtheria, Pertussis and Tetanus

7.2.10.1. Diphtheria, Pertussis and Tetanus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.11. Others

7.2.11.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Pediatrics Vaccines Market By Country 

8.1. North America Pediatrics Vaccines Market Overview

8.2. U.S.

8.2.1. U.S. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

8.2.2. U.S. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

8.2.3. U.S. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.3. Canada

8.3.1. Canada Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

8.3.2. Canada Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

8.3.3. Canada Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Pediatrics Vaccines Market By Country

9.1. Europe Pediatrics Vaccines Market Overview

9.2. U.K.

9.2.1. U.K. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

9.2.2. U.K. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.2.3. U.K. Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.3. Germany

9.3.1. Germany Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

9.3.2. Germany Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.3.3. Germany Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.4. France

9.4.1. France Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

9.4.2. France Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.4.3. France Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.5. Spain

9.5.1. Spain Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

9.5.2. Spain Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.5.3. Spain Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

9.6.2. Rest of Europe Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

9.6.3. Rest of Europe Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Pediatrics Vaccines Market By Country

10.1. Asia Pacific Pediatrics Vaccines Market Overview

10.2. China

10.2.1. China Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.2.2. China Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.2.3. China Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.3. Japan

10.3.1. Japan Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.3.2. Japan Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.3.3. Japan Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.4. India

10.4.1. India Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.4.2. India Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.4.3. India Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.5. Australia

10.5.1. Australia Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.5.2. Australia Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.5.3. Australia Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.6. South Korea

10.6.1. South Korea Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.6.2. South Korea Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.6.3. South Korea Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

10.7.2. Rest of Asia-Pacific Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

10.7.3. Rest of Asia-Pacific Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Pediatrics Vaccines Market By Country

11.1. Latin America Pediatrics Vaccines Market Overview

11.2. Brazil

11.2.1. Brazil Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

11.2.2. Brazil Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.2.3. Brazil Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.3. Mexico

11.3.1. Mexico Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

11.3.2. Mexico Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.3.3. Mexico Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

11.4.2. Rest of Latin America Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

11.4.3. Rest of Latin America Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Pediatrics Vaccines Market By Country 

12.1. Middle East & Africa Pediatrics Vaccines Market Overview

12.2. GCC

12.2.1. GCC Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

12.2.2. GCC Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.2.3. GCC Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.3. South Africa

12.3.1. South Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

12.3.2. South Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.3.3. South Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Vaccine Type, 2020-2032

12.4.2. Rest of Middle East & Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Technology, 2020-2032

12.4.3. Rest of Middle East & Africa Pediatrics Vaccines Revenue (USD Billion) and Forecast By Indication, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Pediatrics Vaccines Market

13.1. Pediatrics Vaccines Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Pediatrics Vaccines Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. GlaxoSmithKline (GSK)

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2022

14.1.3.2. GlaxoSmithKline (GSK) 2022 Pediatrics Vaccines Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Merck & Co., Inc.

14.3. Sanofi Pasteur

14.4. Pfizer Inc.

14.5. Novartis International AG

14.6. CSL Limited

14.7. Johnson & Johnson

14.8. Bavarian Nordic

14.9. Emergent BioSolutions Inc.

14.10. Serum Institute of India Pvt. Ltd.

14.11. Takeda Pharmaceutical Company Limited